The First Affiliated Hospital of Fujian Medical University
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 | 2026-09-24 | NCT07477587 | |
| Comparing Different Doses of Corticosteroids in Local Infiltration Analgesia (LIA) for Total Knee Arthroplasty | Adrenal Cortex Hormones; Anesthesia, Local; Arthroplasty, Replacement, Knee | Recruiting | Not applicable | 2026-01-13 | NCT07337772 | |
| Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery | Cancer Surgery; Dexmedetomidine; Elderly; Long-Term Survivors | Recruiting | Not applicable | 2025-07-31 | NCT06030804 | |
| Postoperative Thrombosis Prevention in Patients With CD | ACTH-dependent Cushing syndrome, Embolism, Embolism and Thrombosis, brain disorder, cardiovascular disorder, central nervous system disorder, endocrine system disorder, hyperpituitarism, hypothalamic disorder, lung disorder, nervous system disorder, pituitary gland disorder, pulmonary embolism, respiratory system disorder, vascular disorder | Active, not recruiting | Not applicable | 2025-07-02 | NCT04486859 | |
| A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer | Advanced Renal Cancer | Active, not recruiting | Phase 3 | 2024-10-15 | NCT04523272 | |
| Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy | hepatocellular carcinoma | Not yet recruiting | Not stated | 2023-07-28 | NCT05965388 |